Cerebral perfusion as a diagnostic marker of early alzheimer’s disease

Neurology

Volumn 38, Issue 6, 1988, Pages 931-937

  Prohovnik, I ^a,b   Mayeux, R ^a,b   Sackeim, H A ^a,b   Smith, G ^a,b   Stern, Y ^a,b   Alderson, P O ^a,b  

^a Columbia University ^*  (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

ADULT; AGED; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; FEMALE; HUMAN; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023943433     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.6.931     Document Type: Article

References (28)

1. Terry R, Katzman R. Senile dementia of the Alzheimer type. Ann Neurol 1983;14:497–506.
2. Gustafson L, Risberg J. Regional cerebral blood flow measurements by the 133-Xe inhalation technique in differential diagnosis of dementia. Acta Psychiatr Scand 1979;60(suppl 72):546–547.
3. Risberg J, Gustafson L. Xe cerebral blood flow in dementia and in neuropsychiatry research. In: Magistretti P, ed. Functional radio-nuclide imaging of the brain. New York: Raven Press, 1983.
4. Duara R, Grady C, Haxby J, et al. Positron emission tomography in Alzheimer’s dieease. Neurology 1986;36:879–887.
5. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987;44:258–262.
6. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stab EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
7. Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: R practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
8. Mayeux R, Stem Y, Roeen J, Leventhal J. Depression, intelledual impairment, and Parkinson’s disease. Neurology 1981;31:645–650.
9. Stern Y, Sano M, Pauleon J, Mayeux R. Modified mini-mental state examination: validity and reliability. Neurology 1987;37(suppl 1):179.
10. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797–811.
11. Berg L, Hughes CP, Coben LA, Danziger WL, Martin RL, Knesevich J. Mild senile dementia of the Alzheimer type: research diagnostic criteria, recruitment and description of a study population. J Neurol Neurosurg Psychiatry 1982;45:962–968.
12. Prohovnik I. Data quality, integrity and interpretation. In: Knezevic S, Maximilian VA, Mubrin Z, Prohovnik I, Wade J, eds. Handbook of regional cerebral blood flow. Hillsdale, NJ Lawrence Erlbaum, 1988.
13. Prohovnik I, Knudaen E, Risberg J. Accuracy of models and algorithm for determination of fast-compartment flow by non-invasive 133-Xe clearance. In: Magiatretti P, ed. Functional radio-nuclide imaging of the brain. New York: Raven Press, 1983:87–115.
14. 133Xe clearance, validation and utility. J Cereb Blood Flow Metab 1987;7(suppl 1):551.
15. Obrist WD, Thompson HK, Wang HS. Regional cerebral blood flow estimated by 133-Xe inhalation. Stroke 1975;6:245–256.
16. Obrist WD, Wilkinson WE. The non-invasive 133-xenon method: evaluation of CBF indices. In: Bee A, Gerand G, eds. Cerebral circulation. Amsterdam: Exerpta Media, 1980:119–124.
17. Prohovnik I, Knudsen E, Rinberg J. Theoretical evaluation and simulation test of the initial slope index for noninvasive rCBF. In: Hartmann A, Hoyer S, eds. Cerebral blood flow and metabolism measurement. Berlin: Springer-Verlag, 1985:56–60.
18. Smith C, Prohovnik I. Regional cerebral perfusion and relative tiesue weight in aging. Soc Neurosci Abstr 1986;12:1313.
19. Frackowiak RS, Pozzilli C, Legg N, et al. Regional cerebral oxygen study and utilization in dementia. Brain 1981;104:649–654.
20. Amano T, Meyer JS, Okabe T, Shaw T. Cerebral vasomotor response during oxygen inhalation: results in normal aging and dementia. Arch Neurol 1983;40:277–282.
21. Friedland R, Budinger T, Ganz E, et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography studies with 18-fluorodeoxyglucose. J Com-put hist Tomogr 1983;7:590–598.
22. Chawluk J, Alavi A, Dann R, et al. Positron emiesion tomography in brain aging and dementia: the effect of focal atrophy on regional metabolic calculations. J Nucl Med 1986;27:945.
23. Meyer JS, Shaw TG, Okaymu H, Tachibana H. Multi-infarct and Alzheimer dementiaa differentiated from normal aging by xenon contrast CT CBF measurementa. J Cereb Blood Flow Metab 1983;3:606–507.
24. Prohovnik I, Smith C, Sackeim H, Mayeux R, Stern Y. The early stages of Alzheimer’s diseaae: initial studies of disease severity and cerebral blood flow. In: Fisher A, Hanin I, Ladiman C, eds. Alzheimer’s and Parkineon’s diseaee: strategiea in research and development. New York Plenum Press, 1986:233–239.
25. Bilder RM, Prohovnik I, Mukhejee S, et al. Cerebral blood flow in schizophrenia: morphological and psychometric correlates. Paper presented at the Annual Meeting of the Society of Biological Psychiatry, 1985.
26. Tatemichi TK, Prohovnik I, Mohr JP, Correll J, Quest DO, Jarvis L. Lose of hypercapnic reactivity in moyamoya disease. Neurology 1987;37(suppl 1):178.
27. Smith G, Prohovnik I, Stem Y, Sano M, Mayeux R. Regional cerebral blood flow and clinical correlates of deterioration in Alzheimer’s disease. Soc Neurosci Abstr 1987;13(3):1628.
28. Mayeux R, Stem Y, Spanton S. Clinical heterogeneity in patients with dementia of the Alzheimer type. Neurology 1985;35:453–461.